2927.T

Second Wind

AFC-HD AMS Life Science Co., Ltd. · Consumer Defensive · Japan · $80M cap · $118K/day traded

JPY 847 +0.7% · close 12 Nov · scored 13 Nov

Second Wind: Cheap with strong momentum, but the business does not earn the optimism.

68
Score
Get score and insider alerts
Quality
37
Value
66
Momentum
61

As of 13 Nov 2026, the MoatMap Score for AFC-HD AMS Life Science Co., Ltd. (2927.T) is 68/100, ranked against 25,000+ stocks in 38 markets (Quality 37, Value 66, Momentum 61, each scored against its sector).

Does the score work? Each tenth of the ranking, tracked monthly. See the record →

P/E (TTM)
10.0x
peers 16.0x
ROE
7.6%
peers 8.1%
D/E
1.4x
peers 0.3x
Dividend %
4.7%
trailing yield

ABOUT AFC-HD AMS LIFE SCIENCE CO., LTD.

Read

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business.

FINANCIAL SUMMARY (JPY)

Year20212022202320242025CAGRTTM
Revenue—23.0B25.6B30.2B32.7B12.4%34.6B
EPS (JPY)106.3052.3378.5189.20102.98-0.8%83.51
Shares—14.0M14.0M14.1M14.1M+0.4%14.7M
Debt—17.1B19.5B22.9B23.9B11.8%23.6B
Equity—12.4B13.1B13.9B15.1B6.6%—
Op CF—1.5B865.3M1.5B1.8B6.2%1.7B
Inv CF—-1.1B-1.9B-2.8B-3.3B——
Fin CF—1.2B1.9B2.2B666.7M——
PRICE (1Y) · JPY-0.5%
82584085586988430 Sep22 Oct12 Nov
SMA 50SMA 200

Price checkNo clear trendExperimental

No clear trend: not near its 52-week low, and not in a steady uptrend.

SwingsVery calm

Calmer than 97% of stocks we rank over the past year (volatility 13% a year).

How this is worked out

The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.

  • Still falling: It set a new 52-week low in the last two weeks, after a deep fall.
  • Finding a floor: It fell hard, but has set no new low for more than two weeks.
  • Turning up: It has climbed off its low and is back above a rising 50-day average.
  • In an uptrend: It is near its 52-week high and above its 200-day average.
  • No clear trend (this stock): None of the above: no recent deep fall and no steady climb.
  • No read yet: Not enough price history yet: it needs a year of trading.

In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.

The exact rules

Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: how much the price moved day to day over the past year, scaled to a yearly figure (annualised volatility) and ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
JPY 847
RSI (14)
43.2
52-Week Range-5.1% from high
Low JPY 790.22High JPY 892.66

SCORE BREAKDOWN

Quality
37
ROIC
10.6%49.4
ROE
7.6%42.4
GP/Assets
24.4%44.1
Op. Margin
7.2%49.0
FCF/Assets
-3.6%12.4
Piotroski
650.1
Int. Cover
11.9x52.1
D/E Ratio
1.42x12.1
Current Ratio
0.84x14.1
Value
66
P/E (TTM)
10.0x78.0
EV/EBITDA
6.6x71.7
P/FCF
—N/A
P/B
0.7x80.9
P/S
0.4x80.0
Div Yield
4.7%76.0
Momentum
61
52W High %
95%85.1
RS 6M
2%53.5
SMA 50/200
1.01x60.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-11%33.5

FUNDAMENTALS

Market Cap
$80M
P/E (Forward)
—
Gross Margin
34.7%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 2927.T are excluded.

TickerCompanyMkt CapScore
2927.TAFC-HD AMS Life Science Co., Ltd.(you)$80M68
3392.TDelica Foods Holdings Co., Ltd.$74M68
8045.TYokohama Maruuo Co., Ltd.$73M64
2937.TSt.Cousair Co., Ltd.$101M72
2903.TShinobu Foods Products Co., Ltd.$105M73
2813.TWakou Shokuhin Co., Ltd.$62M75
2877.TNittoBest Corporation$58M63
2804.TBull-Dog Sauce Co., Ltd.$141M65
2266.TRokko Butter Co., Ltd.$128M63
2922.TNatori Co., Ltd.$158M72

Peer medians: ROE 8.1% · P/E 16.0x · Gross margin 28.4%

Company Deep Dive

A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.

Request Deep Dive(50 Feathers)

AFC-HD AMS Life Science Co., Ltd. (2927.T): Stock Score Summary

AFC-HD AMS Life Science Co., Ltd. (2927.T) has a MoatMap Score of 68/100 based on Quality (37/100), Value (66/100), and Momentum (61/100) factor scores.

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business.

Key Financial Metrics

PriceJPY 847
Market Cap$80M
P/E (TTM)9.95
Price/Book0.74
Return on Equity7.6%
Return on Invested Capital10.6%
Debt/Equity1.42x
Gross Margin34.7%
Operating Margin7.2%
Revenue Growth14.2%
Dividend Yield4.7%
Free Cash Flow$-11M

AFC-HD AMS Life Science Co., Ltd. operates in the Packaged Foods industry, part of the Consumer Defensive sector (Japan).

Frequently Asked Questions

What is AFC-HD AMS Life Science Co., Ltd.’s (2927.T) MoatMap Score?
The MoatMap Score for AFC-HD AMS Life Science Co., Ltd. (2927.T) is 68/100. It is a composite of Quality (37), Value (66), and Momentum (61), each scored against its sector. The composite is then ranked across MoatMap’s universe of 25,000+ stocks.
Does AFC-HD AMS Life Science Co., Ltd. have an economic moat?
AFC-HD AMS Life Science Co., Ltd. (2927.T) has a Quality factor score of 37/100. Quality blends several measures of profitability and financial strength, led by gross profit to assets, return on invested capital and free cash flow to assets. A high score describes the financial record a durable advantage tends to leave; it does not prove a moat.
What sector is AFC-HD AMS Life Science Co., Ltd. in?
AFC-HD AMS Life Science Co., Ltd. (2927.T) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (Japan).